Wyeth Canada: Leading the Way to a Healthier World
Wyeth is a global research-based pharmaceutical company with a long history of pioneering therapies that improve the lives of Canadians, as well as millions of others around the globe. We have grown from our beginnings in Montreal in 1883 to become Canada's leading exporter of pharmaceutical products, distributing to more than 70 countries worldwide.
A division of Wyeth Canada, Wyeth Pharmaceuticals has research-based products in the areas of women's health care, central nervous system disorders, oncology, immunology, palliative care, transplantation, hemophilia and vaccines; and other innovative medicines are on the way. Wyeth is exploring more than 60 new therapies for diabetes, cancer, HIV and Alzheimer's disease.
In Canada, Wyeth is one of the leading pharmaceutical companies in the country. Our more than 1,650 employees across Canada drive all our efforts through their talent, commitment and experience. We all share the same values - quality, collaboration, integrity, respect for people and leadership - that allow us to contribute to our overall corporate goal of being recognized as the best pharmaceutical company in Canada and the world.
Outstanding Global Brands
Pioneering developments in pharmaceuticals have been our heritage. Wyeth remains at the forefront of research into vaccines and biotechnology. Our product portfolio covers a wide range of therapeutic areas including women's health care, neuroscience, musculoskeletal disorders, vaccines and infectious disease treatment, hemophilia, immunology, transplant, palliative care and oncology. Our key global brands include Pristiq®, Xyntha®, Benefix®, Torisel®, Relistor®, Enbrel®, Rapamune®, Prevnar®, Premarin®, Tygacil® and Alesse®.
Towards a healthier tomorrow: Science, Research and Partnerships
At Wyeth, our eyes are on the future and our commitment to research and development is clear evidence of that focus. Wyeth Canada invested $66.5 million (CDN) in 2008 to support research and development in Canada.
Wyeth's state-of-the-art research facility in Montreal, Quebec is a world-class setting for the development of new chemicals and compounds. In Canada, Wyeth researchers are engaged in a number of clinical and post-marketing studies in a range of therapeutic categories.
Français
